Questions 7-11-24 CU answers.pdf
PDF 124 KB Posted
- Attached to
- Forensic Toxicological Testing
- Solicitation number
- 15F06724Q0000214
About this file
This document contains a set of questions and answers related to a Request for Quote (RFQ) issued by the Federal Bureau of Investigation (FBI) for Forensic Toxicological Testing services.
The key details are:
- The FBI requires a laboratory to perform toxicology testing on human blood, urine, and vitreous humor samples, including both qualitative and quantitative testing.
- The procurement will be a firm fixed price per test, with approximately 420 tests performed per period.
- The laboratory does not need to be fully compliant with the ANSI/ASB standards, as long as the compounds tested are known.
- The laboratory can provide uncertainty of measurement data on an as-needed basis, except for DUID reports which must include it.
- The laboratory can provide a monthly status report focusing on metrics like turnaround time and positivity rates, rather than detailed activities and risks.
- Invoices must be submitted through the Invoice Processing Platform (IPP), not a web portal.
- Price adjustments and fee schedule updates at option periods are not acceptable, as the negotiated firm fixed prices will be established at award.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| Toxicological Testing Solicitation.pdf | ||
| FINAL Statement of Work (SOW) FBI Lab Chemistry Unit.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
No. Sheet or
Page
Number
Paragraph/ Section/
Misc
Offeror Question Government Response
1 Page 2 Section 2 Our routine toxicology panels for Postmortem, Human Performance
(DUI/DUID) and DFSA analysis are closely aligned with the current ANSI/ASB
Standards. Future test updates may add or remove compounds from these routine toxicology panels based on market dynamics, declining positivity or operational capabilities.
Would it be acceptable if the laboratory is substantially, but not fully, compliant with the scope of compounds and reporting limits outlined in
ANSI/ASB Standards 119, 120, and 121?
It is acceptable if not all compounds listed are tested for, as long as we know what is being tested for. Knowing this information prior to award may help us determine which potential vendor is best able to meet our needs. SOW lists that that the standards "should" be met, not "must" be met, which may provide flexibility.
2 Page 5 Section 3.2 Our laboratory currently documents Uncertainty of Measurement internally for the majority of our quantitative test results. The Uncertainty of
Measurement data calculation is currently only reported for Human
Performance (DUI/DUID) cases. Including this information with each report for the various types of testing outlined- Postmortem, DFSA, DUID- would not be a deliverable service that we could accommodate at this time.
Would it be acceptable to provide measurements of uncertainty on an "as needed" basis, except for DUID reports, which will include measurements of uncertainty?
It is acceptable to have it reported for all DUID and other tests as needed.
3 Page 7 Section 3.3 Can you please confirm if the 72-hour notification period for a subpoena received for a case submitted by the CU refers to business days?
Business days.
4 Page 7 Section 6 Would it be acceptable to provide only a monthly status report that includes the number of cases submitted, turnaround time, and positivity screen rates, focusing on these metrics instead of describing completed activities, areas of risk, and personnel responsibilities?
The report will be needed on a bi-weekly basis as currently stated in the SOW.
5 Page 8 Section 7 Would it be acceptable to submit invoices and supporting documentation through a no-cost, secure, web-based client portal that also allows for monitoring test orders, order status, test results, and retrieving requested
Litigation Packets, instead of using the Invoice Processing Platform (IPP)?
No, all invoice must be submitted through IPP.
6 Page 2 #2 Description “This procurement will be a firm fixed price per test with approximately 420 test preformed each period.”
If provided with 60 days’ notice before date of option years, would price adjustment requests be acceptable?
No, the negotiated prices will be established at award.
Federal Bureau of Investigation
Request for Quote 15F06724Q0000214
Toxicological Testing
7 Page 2 #2 Description “This procurement will be a firm fixed price per test with approximately 420 test preformed each period.”
Would it be acceptable to update fee schedule catalogue at option period for other tests that may be requested on an ad hoc basis?
No, the negotiated firm fixed prices will be established at award.
File details come from the government source that posted it. Updated .